Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026

エクソソーム研究の世界市場予測(~2026):製品・サービス別、疾患別、用途別、製造サービス別、エンドユーザー別

◆タイトル:Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026
◆商品コード:BT6939-22
◆調査・発行会社:MarketsandMarkets
◆発行日:2022年4月5日
◆ページ数:183
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥0見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥0見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥0見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は、世界のエクソソーム研究市場規模が2021年144百万ドルから2026年661百万ドルまで、年平均35.6%成長すると予想しています。本市場調査資料では、エクソソーム研究の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別(キット・試薬、サービス、機器)分析、疾患別(癌、神経変性疾患、心血管疾患、感染症、その他)分析、用途別(バイオマーカー、ワクチン開発、組織再生、その他)分析、製造サービス別(幹細胞由来エクソソーム製造サービス、樹状細胞由来エクソソーム製造サービス、その他)分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のエクソソーム研究市場規模:製品・サービス別(キット・試薬、サービス、機器)
・世界のエクソソーム研究市場規模:疾患別(癌、神経変性疾患、心血管疾患、感染症、その他)
・世界のエクソソーム研究市場規模:用途別(バイオマーカー、ワクチン開発、組織再生、その他)
・世界のエクソソーム研究市場規模:製造サービス別(幹細胞由来エクソソーム製造サービス、樹状細胞由来エクソソーム製造サービス、その他)
・世界のエクソソーム研究市場規模:地域別
・競争状況
・企業情報

“The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures.”

“By product & service, the kits & reagents segment accounted for the largest share of the exosome research market.”
Based on product and service, the exosomes market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other kits & reagents. Circulating exosomal microRNAs (miRNAs) have emerged as valuable biomarker candidates, making it imperative to characterize these exosomes carefully. This has propelled the use of these entities in exosome research to develop easy-to-use kits and reagents. Additionally, isolation and purification are critical steps in exosome research protocols, contributing to their large-scale adoption in the market.

“Asia Pacific: The fastest-growing region in the exosome research market.”
The Asia Pacific exosome research market is registered to grow at the fastest pace during the forecast period. The rising disposable income, infrastructural developments, and penetration of cutting-edge diagnostic technologies in Asian countries such as India and China offer significant growth opportunities for manufacturers and distributors of exosomes.

“North America: The North America region accounted for the largest share of the exosome research market”
North America accounted for the largest share of the exosome research market. The US is the key revenue contributor to the North American exosome research market. The high prevalence of cancer coupled with the increasing demand for early and effective disease diagnosis and treatment is the key factor driving market growth in the US.
Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs.
The break-up of the primaries is as follows:
By Respondent– Supply Side- 40%, Demand Side- 60%
By Designation— Executives- 25%, CXOs & Directors–30%, Managers – 45%
By Region— North America – 40%, Europe – 25%, APAC – 20%, LATAM- 10%, MEA- 5%

Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Bio-Techne (US), System Biosciences, LLC. (US), NX PharmaGen (US), Miltenyi Biotec (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek Corp. (Canada) are some of the leading players operating in the global exosome research market.

Research Coverage:
The report segments the exosome research market based on region (North America, Europe, Asia Pacific, and Rest of the World), Product & Service (Kits & Reagents (Antibodies, Isolation, Purification, Quantitation Kits & Reagents, Other Kits & Reagents), Instruments, Services), Indication (Cancer (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other Cancers), Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Other Cancers), Application (Biomarkers, Vaccine Development, Tissue Regeneration, and Other Applications), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Testing Laboratories).
The report also provides a comprehensive review of market drivers, challenges, and opportunities in the exosome research market.

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the exosome research market and provides them information on key market drivers, challenges, and opportunities.

【レポートの目次】

1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.2.1 INCLUSIONS & EXCLUSIONS 28
1.3 MARKET SCOPE 29
FIGURE 1 EXOSOME RESEARCH MARKET 29
1.3.1 YEARS CONSIDERED FOR THE STUDY 29
1.4 CURRENCY 30
1.5 LIMITATIONS 30
1.6 STAKEHOLDERS 30
1.7 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 2 RESEARCH DESIGN 32
2.1.1 SECONDARY DATA 33
2.1.2 PRIMARY DATA 34
FIGURE 3 EXOSOME RESEARCH MARKET: BREAKDOWN OF PRIMARIES 34
2.2 MARKET SIZE ESTIMATION 35
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF EXOSOME RESEARCH IN THE MARKET 35
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020 35
FIGURE 6 AVERAGE MARKET SIZE ESTIMATION, 2020 36
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 37
FIGURE 7 EXOSOME RESEARCH MARKET: CAGR PROJECTIONS, 2021–2026 38
FIGURE 8 EXOSOME RESEARCH MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS CHALLENGES, AND OPPORTUNITIES 38
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 39
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 40
FIGURE 10 DATA TRIANGULATION METHODOLOGY 40
2.5 INSIGHTS FROM PRIMARIES 41
FIGURE 11 MARKET VALIDATION FROM PRIMARY EXPERTS 41
2.6 RESEARCH ASSUMPTIONS 41
2.6.1 COVID-19 SPECIFIC ASSUMPTIONS 42
2.7 RISK ANALYSIS 42
3 EXECUTIVE SUMMARY 43
FIGURE 12 EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION) 43
FIGURE 13 EXOSOME RESEARCH MARKET, BY INDICATION,
2021 VS. 2026 (USD MILLION) 44
FIGURE 14 EXOSOME RESEARCH MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 44
FIGURE 15 EXOSOME RESEARCH MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 45
FIGURE 16 GEOGRAPHICAL SNAPSHOT: EXOSOME RESEARCH MARKET 46
4 PREMIUM INSIGHTS 47
4.1 EXOSOME RESEARCH MARKET OVERVIEW 47
FIGURE 17 RISING INVESTMENTS IN THE PHARMACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH 47
4.2 NORTH AMERICA: EXOSOME RESEARCH MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2020) 48
FIGURE 18 KITS & REAGENTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF
NORTH AMERICAN EXOSOME RESEARCH MARKET IN 2020 48
4.3 EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021 VS. 2026 (USD MILLION) 48
FIGURE 19 LUNG CANCER SEGMENT TO DOMINATE THE MARKET IN 2026 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
FIGURE 20 EXOSOME RESEARCH MARKET: DRIVERS, OPPORTUNITIES, RESTRAINTS, AND CHALLENGES 49
TABLE 1 EXOSOME RESEARCH MARKET: IMPACT ANALYSIS 50
5.2.1 DRIVERS 50
5.2.1.1 Increasing investments in pharmaceutical R&D and life science research 50
5.2.1.2 Rising cancer prevalence 51
TABLE 2 GLOBAL CANCER INCIDENCE, 2020 VS. 2025 51
5.2.1.3 Increasing interest in exosome-based procedures 51
5.2.2 RESTRAINTS 52
5.2.2.1 Lack of skilled professionals 52
5.2.3 OPPORTUNITIES 53
5.2.3.1 Untapped emerging markets 53
5.2.3.2 Growing interest in exosome-based therapeutics 53
5.2.3.3 High demand for personalized medicine 54
5.2.4 CHALLENGE 54
5.2.4.1 Lack of gold standard protocols for development & production of exosomes 54
5.3 IMPACT OF COVID-19 OUTBREAK ON EXOSOME RESEARCH MARKET 55
TABLE 3 EXOSOME CONTRIBUTION IN COVID-19 CLINICAL RESEARCH 55
TABLE 4 ONGOING CLINICAL TRIALS FOR EXOSOME-BASED COVID-19 THERAPY 56
5.4 ECOSYSTEM AND VALUE CHAIN ANALYSIS 56
FIGURE 21 EXOSOME RESEARCH MARKET: ECOSYSTEM ANALYSIS 57
5.5 REGULATORY ANALYSIS 59
6 EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE 60
6.1 INTRODUCTION 61
TABLE 5 EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 61
6.2 KITS & REAGENTS 61
TABLE 6 EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 62
TABLE 7 NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 62
TABLE 8 EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 62
TABLE 9 ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 63
TABLE 10 EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 63
6.2.1 ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS 63
6.2.1.1 Rapid and easy-to-use kits and reagents have gained significant demand in the past few years in the market 63
TABLE 11 EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 64
TABLE 12 NORTH AMERICA: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 64
TABLE 13 EUROPE: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 64
TABLE 14 ASIA PACIFIC: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 65
6.2.2 ANTIBODIES 65
6.2.2.1 High demand for exosome-based markers for disease detection is expected to propel the segment growth 65
TABLE 15 EXOSOME RESEARCH ANTIBODIES MARKET, BY REGION,
2019–2026 (USD MILLION) 65
TABLE 16 NORTH AMERICA: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 66
TABLE 17 EUROPE: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 66
TABLE 18 ASIA PACIFIC: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 66
6.2.3 OTHER KITS & REAGENTS 67
TABLE 19 OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 67
TABLE 20 NORTH AMERICA: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 67
TABLE 21 EUROPE: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 68
TABLE 22 ASIA PACIFIC: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 68
6.3 SERVICES 68
6.3.1 PLAYERS OFFER END-TO-END RESEARCH SERVICES FOR LABS 68
TABLE 23 EXOSOME RESEARCH SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 69
TABLE 24 NORTH AMERICA: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 69
TABLE 25 EUROPE: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 69
TABLE 26 ASIA PACIFIC: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 70
6.4 INSTRUMENTS 70
6.4.1 DEMAND FOR SCALABLE DEVELOPMENT OF EXOSOMES VIA HIGH THROUGHPUT SYSTEMS AUGMENTS THE SEGMENT GROWTH 70
TABLE 27 EXOSOME RESEARCH INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 71
TABLE 28 NORTH AMERICA: EXOSOME RESEARCH INSTRUMENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 71
TABLE 29 EUROPE: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 71
TABLE 30 ASIA PACIFIC: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 72
7 EXOSOME RESEARCH MARKET, BY INDICATION 73
7.1 INTRODUCTION 74
TABLE 31 EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION) 74
7.2 CANCER 74
TABLE 32 EXOSOME RESEARCH MARKET FOR CANCER, BY REGION,
2019–2026 (USD MILLION) 75
TABLE 33 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2019–2026 (USD MILLION) 75
TABLE 34 EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY,
2019–2026 (USD MILLION) 75
TABLE 35 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2019–2026 (USD MILLION) 76
TABLE 36 EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 76
7.2.1 LUNG CANCER 76
7.2.1.1 Increasing prevalence of lung cancer and technological advancements in instruments & assays for liquid biopsy to drive market growth 76
TABLE 37 EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY REGION,
2019–2026 (USD MILLION) 77
TABLE 38 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR LUNG CANCER,
BY COUNTRY, 2019–2026 (USD MILLION) 77
TABLE 39 EUROPE: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2019–2026 (USD MILLION) 77
TABLE 40 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR LUNG CANCER,
BY COUNTRY, 2019–2026 (USD MILLION) 78
7.2.2 BREAST CANCER 78
7.2.2.1 High prevalence and increasing awareness to drive the market for this segment 78
TABLE 41 EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY REGION,
2019–2026 (USD MILLION) 78
TABLE 42 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BREAST CANCER,
BY COUNTRY, 2019–2026 (USD MILLION) 79
TABLE 43 EUROPE: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2019–2026 (USD MILLION) 79
TABLE 44 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BREAST CANCER,
BY COUNTRY, 2019–2026 (USD MILLION) 79
7.2.3 PROSTATE CANCER 80
7.2.3.1 Liquid biopsy helps detect aggressive prostate cancer before surgery—a key factor driving market growth 80
TABLE 45 EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY REGION,
2019–2026 (USD MILLION) 80
TABLE 46 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER,
BY COUNTRY, 2019–2026 (USD MILLION) 80
TABLE 47 EUROPE: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER,
BY COUNTRY, 2019–2026 (USD MILLION) 81
TABLE 48 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER,
BY COUNTRY, 2019–2026 (USD MILLION) 81
7.2.4 COLORECTAL CANCER 81
7.2.4.1 Increasing research activities and projects based on exosomes to drive the market for this segment 81
TABLE 49 EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY REGION, 2019–2026 (USD MILLION) 82
TABLE 50 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2019–2026 (USD MILLION) 82
TABLE 51 EUROPE: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER,
BY COUNTRY, 2019–2026 (USD MILLION) 82
TABLE 52 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER,
BY COUNTRY, 2019–2026 (USD MILLION) 83
7.2.5 OTHER CANCERS 83
TABLE 53 EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY REGION,
2019–2026 (USD MILLION) 83
TABLE 54 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER CANCERS,
BY COUNTRY, 2019–2026 (USD MILLION) 84
TABLE 55 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2019–2026 (USD MILLION) 84
TABLE 56 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER CANCERS,
BY COUNTRY, 2019–2026 (USD MILLION) 84
7.3 NEURODEGENERATIVE DISEASES 85
7.3.1 POTENTIAL OF SALIVARY EXOSOMAL CONTENT AS BIOMARKERS HAS OPENED AVENUES IN RESEARCH FOR NEURODEGENERATIVE DISEASES 85
TABLE 57 EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES,
BY REGION, 2019–2026 (USD MILLION) 85
TABLE 58 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION) 85
TABLE 59 EUROPE: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION) 86
TABLE 60 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION) 86
7.4 CARDIOVASCULAR DISEASES 86
7.4.1 GROWING RESEARCH ON EXTRACELLULAR VESICLES FOR CVD TO PROPEL THE SEGMENT GROWTH 86
TABLE 61 EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES,
BY REGION, 2019–2026 (USD MILLION) 87
TABLE 62 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION) 87
TABLE 63 EUROPE: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION) 87
TABLE 64 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION) 88
7.5 INFECTIOUS DISEASES 88
7.5.1 POTENTIAL USE OF EXOSOMES IN DEVELOPING NOVEL COVID-19 TREATMENT SOLUTIONS IS EXPECTED TO DRIVE THE MARKET 88
TABLE 65 EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2019–2026 (USD MILLION) 89
TABLE 66 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019–2026 (USD MILLION) 89
TABLE 67 EUROPE: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION) 89
TABLE 68 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION) 90
7.6 OTHER INDICATIONS 90
TABLE 69 EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY REGION,
2019–2026 (USD MILLION) 90
TABLE 70 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 91
TABLE 71 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 91
TABLE 72 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 91
8 EXOSOME RESEARCH MARKET, BY APPLICATION 92
8.1 INTRODUCTION 93
TABLE 73 EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 93
8.2 BIOMARKERS 93
8.2.1 BIOMARKERS FORM THE LARGEST APPLICATION SEGMENT 93
TABLE 74 EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY REGION,
2019–2026 (USD MILLION) 94
TABLE 75 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS,
BY COUNTRY, 2019–2026 (USD MILLION) 94
TABLE 76 EUROPE: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2019–2026 (USD MILLION) 94
TABLE 77 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BIOMARKERS,
BY COUNTRY, 2019–2026 (USD MILLION) 95
8.3 VACCINE DEVELOPMENT 95
8.3.1 POTENTIAL OF EXOSOMES TO COMBAT BACTERIAL INFECTIONS DRIVING INTEREST IN VACCINE APPLICATIONS 95
TABLE 78 EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY REGION, 2019–2026 (USD MILLION) 95
TABLE 79 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 96
TABLE 80 EUROPE: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT,
BY COUNTRY, 2019–2026 (USD MILLION) 96
TABLE 81 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 96
8.4 TISSUE REGENERATION 97
8.4.1 STUDIES CONDUCTED ON MOLECULAR PAYLOADS OF EXOSOMES TO ENHANCE TISSUE REGENERATION DRIVES MARKET GROWTH 97
TABLE 82 EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY REGION, 2019–2026 (USD MILLION) 97
TABLE 83 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2019–2026 (USD MILLION) 97
TABLE 84 EUROPE: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION,
BY COUNTRY, 2019–2026 (USD MILLION) 98
TABLE 85 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2019–2026 (USD MILLION) 98
8.5 OTHER APPLICATIONS 98
TABLE 86 EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 99
TABLE 87 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 88 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 89 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 100
9 EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE 101
9.1 INTRODUCTION 102
TABLE 90 EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE,
2019–2026 (USD MILLION) 102
9.2 STEM CELL-DERIVED EXOSOME MANUFACTURING SERVICES 102
9.2.1 INCREASED DEMAND FOR MSC-EXOSOMES IN THERAPEUTICS AUGMENTS THE SEGMENT GROWTH 102
9.3 DENDRITIC CELL-DERIVED EXOSOME MANUFACTURING SERVICES 103
9.3.1 SIGNIFICANT DEVELOPMENTS IN DC-EXOSOME IMMUNOTHERAPY TO DRIVE MARKET GROWTH 103
9.4 OTHER MANUFACTURING SERVICES 103
10 EXOSOME RESEARCH MARKET, BY END USER 104
10.1 INTRODUCTION 105
TABLE 91 EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION) 105
10.2 ACADEMIC & RESEARCH INSTITUTES 105
10.2.1 ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS IN
THE EXOSOME RESEARCH MARKET 105
TABLE 92 EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2019–2026 (USD MILLION) 106
TABLE 93 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 106
TABLE 94 EUROPE: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 107
TABLE 95 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 107
10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 107
10.3.1 SIGNIFICANT DEVELOPMENTS IN NANOMEDICINE TO DRIVE MARKET GROWTH IN THIS END-USER SEGMENT 107
TABLE 96 EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 108
TABLE 97 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 108
TABLE 98 EUROPE: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 108
TABLE 99 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 109
10.4 HOSPITAL & CLINICAL TESTING LABORATORIES 109
10.4.1 INCREASE IN ADOPTION OF EXOSOME-BASED ONCOLOGY RESEARCH SOLUTIONS TO DRIVE MARKET GROWTH IN THIS END-USER SEGMENT 109
TABLE 100 EXOSOME RESEARCH MARKET FOR HOSPITAL & CLINICAL TESTING LABORATORIES, BY REGION, 2019–2026 (USD MILLION) 109
TABLE 101 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 110
TABLE 102 EUROPE: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 110
TABLE 103 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 110
11 EXOSOME RESEARCH MARKET, BY REGION 111
11.1 INTRODUCTION 112
TABLE 104 EXOSOME RESEARCH MARKET, BY REGION, 2019–2026 (USD MILLION) 112
11.2 NORTH AMERICA 113
FIGURE 22 NORTH AMERICA: EXOSOME RESEARCH MARKET SNAPSHOT 113
TABLE 105 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 114
TABLE 106 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 114
TABLE 107 NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 114
TABLE 108 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 115
TABLE 109 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION) 115
TABLE 110 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 115
TABLE 111 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 116
11.2.1 US 116
11.2.1.1 High burden of cancer and favorable public and private funding for research activities to drive market growth 116
FIGURE 23 US CONTINUES TO DOMINATE THE DISTRIBUTION OF R&D COMPANIES
BY REGION/COUNTRY (2021) 116
TABLE 112 US: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 117
TABLE 113 US: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 117
TABLE 114 US: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 117
TABLE 115 US: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 118
TABLE 116 US: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 118
TABLE 117 US: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 118
11.2.2 CANADA 119
11.2.2.1 Increasing funding for genome-based medical treatments to support market growth 119
TABLE 118 CANADA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 119
TABLE 119 CANADA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 120 CANADA: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 120
TABLE 121 CANADA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 122 CANADA: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 121
TABLE 123 CANADA: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 121
11.3 EUROPE 122
FIGURE 24 EUROPE: EXOSOME RESEARCH MARKET SNAPSHOT 122
TABLE 124 EUROPE: EXOSOME RESEARCH MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 123
TABLE 125 EUROPE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 123
TABLE 126 EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 127 EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 124
TABLE 128 EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 124
TABLE 129 EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 124
TABLE 130 EUROPE: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 125
11.3.1 GERMANY 125
11.3.1.1 Strong academic research base bolsters market growth 125
TABLE 131 GERMANY: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 125
TABLE 132 GERMANY: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 133 GERMANY: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 126
TABLE 134 GERMANY: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 126
TABLE 135 GERMANY: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 127
TABLE 136 GERMANY: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 127
11.3.2 UK 127
11.3.2.1 Growth in the life sciences industry to drive the market for exosome research in the UK 127
TABLE 137 UK: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 128
TABLE 138 UK: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 139 UK: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 128
TABLE 140 UK: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 129
TABLE 141 UK: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 129
TABLE 142 UK: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 129
11.3.3 FRANCE 130
11.3.3.1 Strong collaborative network between biotechnology entities and research institutes drives market growth 130
TABLE 143 FRANCE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 130
TABLE 144 FRANCE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 145 FRANCE: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 131
TABLE 146 FRANCE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 147 FRANCE: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 131
TABLE 148 FRANCE: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 132
11.3.4 REST OF EUROPE 132
TABLE 149 ROE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 132
TABLE 150 ROE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 133
TABLE 151 ROE: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 133
TABLE 152 ROE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 133
TABLE 153 ROE: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 134
TABLE 154 ROE: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 134
11.4 ASIA PACIFIC 135
TABLE 155 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 135
TABLE 156 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 135
TABLE 157 ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 158 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 136
TABLE 159 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 136
TABLE 160 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 137
TABLE 161 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 137
11.4.1 CHINA 137
11.4.1.1 Government initiatives to strengthen the biotechnology industry and the high prevalence of cancer are major factors driving market growth 137
TABLE 162 CHINA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 138
TABLE 163 CHINA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 164 CHINA: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 138
TABLE 165 CHINA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 139
TABLE 166 CHINA: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 139
TABLE 167 CHINA: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 139
11.4.2 JAPAN 140
11.4.2.1 High prevalence of cancer and increasing healthcare expenditure are the key drivers for the exosome research market in the country 140
TABLE 168 JAPAN: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 140
TABLE 169 JAPAN: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 170 JAPAN: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 141
TABLE 171 JAPAN: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 172 JAPAN: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 141
TABLE 173 JAPAN: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 142
11.4.3 REST OF ASIA PACIFIC 142
TABLE 174 ROAPAC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 142
TABLE 175 ROAPAC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 176 ROAPAC: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 143
TABLE 177 ROAPAC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 178 ROAPAC: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 144
TABLE 179 ROAPAC: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 144
11.5 REST OF THE WORLD 144
TABLE 180 ROW: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 145
TABLE 181 ROW: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 182 ROW: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION) 145
TABLE 183 ROW: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 184 ROW: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 146
TABLE 185 ROW: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION) 146
12 COMPETITIVE LANDSCAPE 147
12.1 INTRODUCTION 147
12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 147
FIGURE 25 EXOSOME RESEARCH MARKET: STRATEGIES ADOPTED 147
12.3 MARKET SHARE ANALYSIS 148
FIGURE 26 EXOSOME RESEARCH MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2020) 148
12.4 COMPANY EVALUATION QUADRANT 150
12.4.1 STARS 150
12.4.2 EMERGING LEADERS 150
12.4.3 PERVASIVE PLAYERS 150
12.4.4 PARTICIPANTS 150
FIGURE 27 EXOSOME RESEARCH MARKET: COMPANY EVALUATION MATRIX, 2020 (TOP 10 PLAYERS) 151
12.5 COMPETITIVE BENCHMARKING 152
12.5.1 COMPANY SERVICE FOOTPRINT (10 COMPANIES) 152
FIGURE 28 SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN EXOSOME RESEARCH MARKET 152
12.6 COMPETITIVE SCENARIO AND TRENDS 153
12.6.1 DEALS (2016–2019) 153
TABLE 186 EXOSOME RESEARCH MARKET: DEALS 153
12.6.2 PRODUCT LAUNCHES (2016–2019) 154
TABLE 187 EXOSOME RESEARCH MARKET: PRODUCT LAUNCHES 154
12.6.3 OTHER DEVELOPMENTS (2016–2019) 154
TABLE 188 EXOSOME RESEARCH MARKET: OTHER DEVELOPMENTS 154
13 COMPANY PROFILES 155
13.1 KEY COMPANIES 155
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1 THERMO FISHER SCIENTIFIC, INC. 155
TABLE 189 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 155
FIGURE 29 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 156
TABLE 190 THERMO FISHER SCIENTIFIC, INC.: PRODUCT OFFERINGS 156
TABLE 191 THERMO FISHER SCIENTIFIC, INC.: EXPANSIONS 157
13.1.2 SYSTEM BIOSCIENCES, LLC. 159
TABLE 192 SYSTEM BIOSCIENCES LLC: BUSINESS OVERVIEW 159
TABLE 193 SYSTEM BIOSCIENCES: PRODUCT & SERVICE OFFERINGS 159
TABLE 194 SYSTEM BIOSCIENCES LLC: DEALS 160
13.1.3 BIO-TECHNE 161
TABLE 195 BIO-TECHNE: BUSINESS OVERVIEW 161
FIGURE 30 BIO-TECHNE: COMPANY SNAPSHOT 162
TABLE 196 BIO-TECHNE: PRODUCT OFFERINGS 162
TABLE 197 BIO-TECHNE: PRODUCT LAUNCHES 163
TABLE 198 BIO-TECHNE: DEALS 163
13.1.4 QIAGEN 165
TABLE 199 QIAGEN: BUSINESS OVERVIEW 165
FIGURE 31 QIAGEN: COMPANY SNAPSHOT 166
TABLE 200 QIAGEN: PRODUCT OFFERINGS 166
TABLE 201 QIAGEN: DEALS 167
13.1.5 LONZA 169
TABLE 202 LONZA: BUSINESS OVERVIEW 169
FIGURE 32 LONZA: COMPANY SNAPSHOT 170
TABLE 203 LONZA: SERVICE OFFERINGS 170
TABLE 204 LONZA: DEALS 171
13.1.6 NX PHARMAGEN 172
TABLE 205 NX PHARMAGEN: BUSINESS OVERVIEW 172
TABLE 206 NX PHARMAGEN: SERVICE OFFERINGS 172
13.1.7 AMSBIO (AMS BIOTECHNOLOGY) 173
TABLE 207 AMSBIO: BUSINESS OVERVIEW 173
TABLE 208 AMSBIO: PRODUCT OFFERINGS 173
13.1.8 NANOSOMIX, INC. 174
TABLE 209 NANOSOMIX, INC.: BUSINESS OVERVIEW 174
TABLE 210 NANOSOMIX: PRODUCT OFFERINGS 174
13.1.9 MILTENYI BIOTEC 175
TABLE 211 MILTENYI BIOTEC: BUSINESS OVERVIEW 175
TABLE 212 MILTENYI BIOTEC: PRODUCT OFFERINGS 175
13.1.10 NORGEN BIOTEK CORP. 176
TABLE 213 NORGEN BIOTEK CORP.: BUSINESS OVERVIEW 176
TABLE 214 NORGEN BIOTEK: PRODUCT OFFERINGS 176
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS 177
13.2.1 AETHLON MEDICAL, INC. 177
TABLE 215 AETHLON MEDICAL, INC.: COMPANY OVERVIEW 177
13.2.2 ANJARIUM BIOSCIENCES AG 177
TABLE 216 ANJARIUM BIOSCIENCES AG: COMPANY OVERVIEW 177
13.2.3 CILOA 178
TABLE 217 CILOA: COMPANY OVERVIEW 178
13.2.4 CLARA BIOTECH, INC. 178
TABLE 218 CLARA BIOTECH, INC.: COMPANY OVERVIEW 178
13.2.5 CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. 179
TABLE 219 CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.: COMPANY OVERVIEW 179
13.2.6 ILIAS BIOLOGICS, INC. 179
TABLE 220 ILIAS BIOLOGICS, INC.: COMPANY OVERVIEW 179
13.2.7 NANOVIEW BIOSCIENCES 180
TABLE 221 NANOVIEW BIOSCIENCES: COMPANY OVERVIEW 180
13.2.8 RION, LLC 180
TABLE 222 RION, LLC: COMPANY OVERVIEW 180
13.2.9 CELL GUIDANCE SYSTEMS LLC 181
TABLE 223 CELL GUIDANCE SYSTEMS: COMPANY OVERVIEW 181
13.2.10 INOVIQ (BARD1 LIFE SCIENCES LTD.) 181
TABLE 224 INOVIQ: COMPANY OVERVIEW 181
13.2.11 NOVUS BIOLOGICALS 182
TABLE 225 NOVUS BIOLOGICALS: COMPANY OVERVIEW 182
13.2.12 BIOVISION INC. 182
TABLE 226 BIOVISION INC.: COMPANY OVERVIEW 182
13.2.13 PALL CORPORATION 183
TABLE 227 PALL CORPORATION: COMPANY OVERVIEW 183
13.2.14 EXOPHARM 183
TABLE 228 EXOPHARM: COMPANY OVERVIEW 183
13.2.15 EVERZOM 184
TABLE 229 EVERZOM: COMPANY OVERVIEW 184
14 APPENDIX 185
14.1 DISCUSSION GUIDE 185
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 188
14.3 AVAILABLE CUSTOMIZATIONS 190
14.4 RELATED REPORT 190
14.5 AUTHOR DETAILS 191



★調査レポート[エクソソーム研究の世界市場予測(~2026):製品・サービス別、疾患別、用途別、製造サービス別、エンドユーザー別] ( Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026 / BT6939-22) 販売に関する免責事項
[エクソソーム研究の世界市場予測(~2026):製品・サービス別、疾患別、用途別、製造サービス別、エンドユーザー別] ( Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026 / BT6939-22) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆